Thursday, March 12, 2026
HomePharma

Pharma

Pharma

Silence Therapeutics Presents New Analysis from SLN360 Phase 1 Single Dose Study in High Lipoprotein(a)

Life Sciences Times - 0
Pharma

Kezar Life Sciences Presents Positive Complete Results from the MISSION Phase 2 Trial Evaluating Zetomipzomib in Lupus Nephritis

Life Sciences Times - 0
Pharma

U.S. Food and Drug Administration Approves Vemlidy® (tenofovir alafenamide) for Treatment of Chronic Hepatitis B Virus Infection in Pediatric Patients

Life Sciences Times - 0
Pharma

Noramco Announces Submission and Reactivation of the Drug Master File for Active Pharmaceutical Ingredient Methylnaltrexone Bromide

Life Sciences Times - 0
Pharma

Bristol Myers Squibb Announces Positive Topline Results of Phase 3 COMMANDS Trial

Life Sciences Times - 0
Pharma

Takeda Becomes First Enterprise to Achieve Diamond Tier Status as a Best in Resilience™ Certified Organization

Life Sciences Times - 0
Pharma

Milla Pharmaceuticals Inc. and the Alter Pharma Group Announce First Paragraph IV Filing and Acceptance by FDA

Life Sciences Times - 0
Pharma

Gilead Presents Real-World Evidence Reinforcing the Use of Biktarvy® for the Treatment of People Living With HIV With a Range of Comorbidities

Life Sciences Times - 0
Pharma

Novaliq Announces FDA Acceptance of the New Drug Application for CyclASol® for the Treatment of Dry Eye Disease

Life Sciences Times - 0
Pharma

Teva Announces Results from 3-Year Study Assessing the Safety and Tolerability of AUSTEDO® Tablets for the Treatment of Chorea Associated with Huntington’s Disease

Life Sciences Times - 0
Pharma

Mirum Pharmaceuticals Announces Positive CHMP Opinion for LIVMARLI® (maralixibat) Oral Solution for Cholestatic Pruritus

Life Sciences Times - 0
Pharma

CHMP recommends conditional marketing authorization for Spesolimab as first in class treatment option for generalized pustular psoriasis flares

Life Sciences Times - 0
1...434445...88Page 44 of 88

Most Read

EDITOR PICKS

THIS WEEK'S STORIES

POPULAR CATEGORY

ABOUT US

Life Science Times is New England’s premier life sciences publication, covering the Pharma, Biotech, MedTech and Public Health sectors nationwide with a special focus on New England. Updated daily, we cover the latest news in everything else that touches any rubric of the rapidly growing life sciences industry.

Contact us: editorial@mishragroup.com

FOLLOW US

© Newspaper WordPress Theme by TagDiv